We are live on ! Find out more
AHL

Abel Hall LLC Portfolio holdings

AUM $579M
1-Year Est. Return 54.21%
This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+54.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$469M
AUM Growth
+$41.3M
Cap. Flow
+$37.4M
Cap. Flow %
7.96%
Top 10 Hldgs %
26.59%
Holding
991
New
277
Increased
304
Reduced
174
Closed
180

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.21M
2
TSLA icon
Tesla
TSLA
+$1.27M
3
JPM icon
JPMorgan Chase
JPM
+$1.26M
4
META icon
Meta Platforms (Facebook)
META
+$1.19M
5
MA icon
Mastercard
MA
+$1.14M

Sector Composition

Rank Sector Weight
1 Technology 16.39%
2 Financials 9.72%
3 Healthcare 7.86%
4 Industrials 7.53%
5 Energy 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXT icon
776
Rackspace Technology
RXT
$967M
$29.9K 0.01%
+30,559
New +$37.1K
LUCD icon
777
Lucid Diagnostics
LUCD
$174M
$29.6K 0.01%
25,728
-4,893
-16% -$6.23K
AIRJ
778
Montana Technologies Corp
AIRJ
$313M
$26.8K 0.01%
10,691
-1,068
-9% -$3.6K
OCGN icon
779
Ocugen
OCGN
$420M
$26.7K 0.01%
14,778
UIS icon
780
Unisys
UIS
$250M
$26.6K 0.01%
+12,861
New +$32.3K
CCCC icon
781
C4 Therapeutics
CCCC
$393M
$26.5K 0.01%
10,088
-52
-0.5% -$122
EVEX icon
782
Eve Holding
EVEX
$853M
$25.6K 0.01%
10,341
-3,100
-23% -$10.6K
ALDX icon
783
Aldeyra Therapeutics
ALDX
$95.3M
$25.6K 0.01%
+15,142
New +$66.3K
ALXO icon
784
ALX Oncology
ALXO
$268M
$25.3K 0.01%
12,598
FSP
785
Franklin Street Properties
FSP
$50.1M
$25.1K 0.01%
37,818
-15,003
-28% -$11.6K
IKT icon
786
Inhibikase Therapeutics
IKT
$363M
$24.5K 0.01%
+14,563
New +$25.9K
SES icon
787
SES AI
SES
$196M
$22.2K ﹤0.01%
23,063
ALIT icon
788
Alight
ALIT
$523M
$20.1K ﹤0.01%
+1,727
New +$41.2K
STXS icon
789
Stereotaxis
STXS
$128M
$19.9K ﹤0.01%
10,826
-12,131
-53% -$26.6K
URG
790
Ur-Energy
URG
$481M
$19.3K ﹤0.01%
12,981
CERS icon
791
Cerus
CERS
$585M
$19.3K ﹤0.01%
10,621
-928
-8% -$2.02K
TEAD
792
Teads Holding Co
TEAD
$78.6M
$19.1K ﹤0.01%
29,048
-43,261
-60% -$30.7K
DH icon
793
Definitive Healthcare
DH
$74.6M
$18K ﹤0.01%
+14,621
New +$25.4K
HURA
794
TuHURA Biosciences
HURA
$136M
$17.9K ﹤0.01%
+10,027
New +$12.3K
SABR icon
795
Sabre
SABR
$743M
$17.7K ﹤0.01%
+12,212
New +$16.3K
ZSPC
796
DELISTED
ZSPACE INC NEW
ZSPC
$17.7K ﹤0.01%
6,236
+5,506
+754% +$45.7K
OABI icon
797
OmniAb
OABI
$286M
$16.8K ﹤0.01%
+10,704
New +$19.3K
HRTX icon
798
Heron Therapeutics
HRTX
$92M
$13.5K ﹤0.01%
16,907
-29,269
-63% -$33.9K
MVIS icon
799
Microvision
MVIS
$86.6M
$12.7K ﹤0.01%
+19,839
New +$15.1K
SLQT icon
800
SelectQuote
SLQT
$132M
$12.7K ﹤0.01%
+20,109
New +$21.1K

Similar funds

Abel Hall LLC's Q1 2026 Portfolio in Review

As of Q1 2026, Abel Hall LLC held 991 positions worth $469M, up 9.6% from $428M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Abel Hall LLC deployed $37.4M of net new capital in Q1 2026, opening 277 new positions and adding to 304 existing holdings. Its largest new stake was SM Energy: 54,094 shares worth $1.69M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $2.21M trimmed.

  • Abel Hall LLC's largest Q1 2026 buy was SM Energy: 54,094 shares worth $1.69M.
  • Abel Hall LLC added most to Dimensional US Core Equity 2 ETF in Q1 2026, an estimated $2.05M increase.
  • Abel Hall LLC's biggest Q1 2026 reduction was Microsoft, cutting an estimated $2.21M.
  • Abel Hall LLC fully exited Blackrock in Q1 2026, selling an estimated $792K.
  • Abel Hall LLC's ten largest holdings make up 27% of its $469M portfolio in Q1 2026.
  • Abel Hall LLC opened 277 new positions and closed 180 in Q1 2026.
  • Abel Hall LLC's portfolio value rose 9.6% quarter-over-quarter to $469M.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.